US 12247201
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
granted A61KA61K31/7088A61K38/465
Quick answer
US patent 12247201 (Materials and methods for treatment of autosomal dominant retinitis pigmentosa) held by CRISPR THERAPEUTICS AG expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/7088, A61K38/465, A61P, A61P27/02